US Bancorp’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-750
| Closed | -$29.5K | – | 4172 |
|
|
2023
Q2 | $29.5K | Sell |
750
-59
| -7% | -$2.08K | ﹤0.01% | 2771 |
|
|
2023
Q1 | $19.7K | Sell |
809
-963
| -54% | -$21.1K | ﹤0.01% | 3004 |
|
|
2022
Q4 | $37.9K | Sell |
1,772
-23,673
| -93% | -$505K | ﹤0.01% | 2674 |
|
|
2022
Q3 | $457K | Buy |
25,445
+25,282
| +15,510% | +$332K | ﹤0.01% | 1432 |
|
|
2022
Q2 | $2K | Sell |
163
-931
| -85% | -$11.7K | ﹤0.01% | 3905 |
|
|
2022
Q1 | $18K | Buy |
1,094
+78
| +8% | +$1.15K | ﹤0.01% | 3151 |
|
|
2021
Q4 | $17K | Hold |
1,016
| – | – | ﹤0.01% | 3222 |
|
|
2021
Q3 | $17K | Buy |
1,016
+255
| +34% | +$2.77K | ﹤0.01% | 3224 |
|
|
2021
Q2 | $5K | Buy |
761
+717
| +1,630% | +$4.63K | ﹤0.01% | 3640 |
|
|
2021
Q1 | $0 | Buy |
+44
| New | +$267 | ﹤0.01% | 3998 |
|
|
2018
Q4 | – | Sell |
-56,500
| Closed | -$133K | – | 3733 |
|
|
2018
Q3 | $133K | Hold |
56,500
| – | – | ﹤0.01% | 2085 |
|
|
2018
Q2 | $154K | Sell |
56,500
-8,200
| -13% | -$22.6K | ﹤0.01% | 2012 |
|
|
2018
Q1 | $177K | Hold |
64,700
| – | – | ﹤0.01% | 1933 |
|
|
2017
Q4 | $201K | Hold |
64,700
| – | – | ﹤0.01% | 1883 |
|
|
2017
Q3 | $182K | Hold |
64,700
| – | – | ﹤0.01% | 1910 |
|
|
2017
Q2 | $165K | Hold |
64,700
| – | – | ﹤0.01% | 1937 |
|
|
2017
Q1 | $237K | Sell |
64,700
-1,704
| -3% | -$7.2K | ﹤0.01% | 1744 |
|
|
2016
Q4 | $320K | Buy |
66,404
+394
| +0.6% | +$11.7K | ﹤0.01% | 1573 |
|
|
2016
Q3 | $3.04M | Buy |
66,010
+75
| +0.1% | +$4.23K | 0.01% | 590 |
|
|
2016
Q2 | $3.36M | Buy |
65,935
+188
| +0.3% | +$9.34K | 0.01% | 541 |
|
|
2016
Q1 | $2.78M | Buy |
65,747
+6
| +0% | +$306 | 0.01% | 603 |
|
|
2015
Q4 | $5.16M | Buy |
65,741
+27,541
| +72% | +$1.59M | 0.02% | 444 |
|
|
2015
Q3 | $1.55M | Buy |
38,200
+20,000
| +110% | +$1.06M | 0.01% | 776 |
|
|
2015
Q2 | $947K | Buy |
18,200
+8,200
| +82% | +$408K | ﹤0.01% | 1055 |
|
|
2015
Q1 | $465K | Sell |
10,000
-325
| -3% | -$16.9K | ﹤0.01% | 1390 |
|
|
2014
Q4 | $464K | Buy |
+10,325
| New | +$434K | ﹤0.01% | 1363 |
|
US Bancorp's ISEE Position: Q3 2023 in Review
US Bancorp sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 750 shares — an estimated $29.5K sold.
US Bancorp first reported a position in ISEE in Q4 2014 and held it in 26 quarters. The position peaked at $5.16M in Q4 2015. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- US Bancorp reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- US Bancorp sold 750 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $29.5K.
- US Bancorp first reported a position in IVERIC bio, Inc. Common Stock in Q4 2014 and held it in 26 quarters.
- US Bancorp's IVERIC bio, Inc. Common Stock position peaked at $5.16M in Q4 2015.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on US Bancorp's 13F filing for Q3 2023, filed 3 Nov 2023.